MGS to showcase global expansion and healthcare CDMO expertise

At MD&M West MGS will exhibit at booth #2827 and highlight its growing global footprint.

Inside view of MGS’s 300,000ft2 state-of-the-art injection molding manufacturing facility in Richfield, Wisconsin
Inside view of MGS’s 300,000ft2 state-of-the-art injection molding manufacturing facility in Richfield, Wisconsin
CREDIT: MGS

MGS, a leading healthcare contract development and manufacturing organization (CDMO), is excited to announce its participation in MD&M West, North America’s premier medical device manufacturing show, taking place February 4-6, 2025, in Anaheim, California. At booth 2827, experts will be on-hand from MGS and its design and development firm, Technolution, to highlight the company’s expanding global manufacturing footprint and demonstrate how its vertically integrated solutions help medical device manufacturers worldwide accelerate speed-to-market and streamline their supply chains.

During the past 18 months, MGS has invested significantly in global growth to better serve Pharmaceutical, Diagnostic and MedTech innovators worldwide. Highlights of these investments include:

  • Completion of the MGS Innovation Center located in Germantown, Wisconsin, purpose-built to foster collaboration and innovation. It brings together MGS’ Engineering Services Group, with workspaces dedicated to product design and development, tooling, automation, sampling and more.
  • A new 300,000ft2 state-of-the-art manufacturing facility in Richfield, Wisconsin, with 140,000ft2 of ISO Class 8 cleanroom space, over 100 injection molding machines and next-generation automation capabilities to meet the needs of Pharma innovators.
  • The Richfield site is complemented by the forthcoming Costa Rica facility and the enhanced capabilities it will bring to support high-volume manufacturing, including advanced white room environments and precision automation for drug delivery devices and diagnostic products.
  • Updates to its Juarez, Mexico healthcare manufacturing facility, including expanded injection molding capacity, enhanced secondary operations like packaging and ultrasonic welding, and a vertically integrated approach to tooling, automation and manufacturing.
  • Additional expansion to MGS’ facility in Leixlip, Ireland serves European customer needs from product design and development to manufacturing along with dedicated cleanrooms and a state-of-the-art Quality Lab. 

“Our experts are excited to showcase our growing capacity and expertise at MD&M West, particularly the benefits of how this expansion is accelerating growth for Pharma, Diagnostic and MedTech companies around the world,” said MGS President and CEO Paul Manley. “We’ve strategically invested in expanding our footprint to build capacity when and where our customers need it, enabling us to deliver the speed, quality and efficiency required to bring life-changing products to market.”

At MD&M West, visitors can connect with experts from MGS and its design and development firm, Technolution, to explore the benefits of working with a single-source partner. Dedicated experts for both teams will be on hand to discuss the company’s expertise in autoinjector pens, including how to accelerate development through its proprietary autoinjector pen platform. With capabilities spanning from napkin sketch to manufacturing and assembly, MGS offers an end-to-end solution to help innovators consolidate their supply chain and focus on creating greater value for patients.